Epigenetic alterations
The epigenome is the layer of chemical switches on your DNA that decides which genes are on in each cell, and it drifts out of tune as you age. That drift is real, it is reversible in principle, and it is what "epigenetic clocks" read to estimate your biological age. What is oversold is everything built on top: a consumer clock reading is too noisy to act on, the trials that moved a clock found small effects, and the dramatic "age reversal" results come from one small pilot and from mice.
Don't buy an epigenetic age test, and don't buy anything sold to lower one. Eat well, don't overeat, exercise, and take loud snoring or daytime sleepiness to a doctor, because these are good for your health whatever a clock says. If you test anyway, use one provider, one sample type and blood rather than saliva, and never change treatment on the result.
Why your genes explain less than you might think
Your DNA sequence is essentially fixed for life, yet inherited gene variants explain only a minority of the variation in how long people live: about 20–25% in twin studies, and well under 10% in a family-tree study of people born in the 1800s and early 1900s once it allowed for people tending to marry partners who share lifespan-shaping traits and circumstances.[1] That is a statement about spread across a population, not about any one person's lifespan.
The split is contested. A 2026 reanalysis argues these estimates are deflated by deaths from accidents and infections, and puts the heritability of intrinsic ageing above 50% once those are stripped out.[2] This site does not pick a number, and the case for behaviour does not rest on one.
Much of what is not inherited reaches your genes through the epigenome: reversible chemical marks on top of the DNA that control which genes are switched on without changing the code itself. Epigenetic alteration is the third of the twelve hallmarks of aging. As we age, that control layer degrades, cells lose their precise identities, and tissues drift away from the gene-activity patterns of youth.[3]
How the switches work, and how they drift
Three systems make up the epigenome. DNA methylation, the best studied, attaches small chemical tags (methyl groups) at specific spots on the DNA; a cluster of them on a gene's control region usually switches the gene off, which is how a liver cell stays a liver cell. Histone modifications are tags on the protein spools DNA is wound around, loosening or tightening the packing to open or shut genes. Non-coding RNAs fine-tune which genes are read. Unlike a mutation, which is a permanent typo in the code (see genomic instability), all of these marks can be erased and rewritten.
The age-related drift runs in two directions, and this is one of the best-replicated findings in the field.[4]
- Global loss of methylation. Across the genome, tags are gradually lost, especially from long stretches of repetitive DNA that are normally kept silent. Among them are "jumping genes" (transposable elements), ancient stretches of parasitic DNA that can reactivate when their silencing erodes, adding to genetic damage and to sterile inflammation, meaning inflammation with no infection behind it.[5] The evidence for the inflammation link comes from senescent cells grown in the lab and from old mice, in which a drug that blocks the jumping genes' copying enzyme calmed age-related inflammation; it has not been shown in people.[6] It is one of the threads tying this hallmark to inflammaging.
- Local gain of methylation. At the same time, tags pile up on the control regions of important genes, including tumour-suppressor genes and genes governing cell identity and repair, switching them off when they are needed.[7]
A parallel change is the gradual unravelling of heterochromatin, the densely packed, switched-off regions of the genome.[8] The same machinery is destabilised in the accelerated-aging disease progeria.
Sirtuins: real biology, no pill
Because enzymes write and erase the marks, they are obvious drug targets, and in mice the results are striking. Blocking the enzymes that remove acetyl tags (histone deacetylases) prevented age-related memory loss, and switching off a tag-adding enzyme called KAT7 relieved cellular senescence and extended lifespan.[9] These are proofs of principle in animals, not human therapies.
The best known of these enzymes are the sirtuins. They only work when fuelled by nicotinamide adenine dinucleotide (NAD⁺), a molecule whose levels fall with age, and mice lacking one of them, SIRT6, age faster.[10] The leap from there to "sirtuin-boosting supplements extend life" is not supported. The early worm and fly lifespan results largely disappeared once genetic background was properly controlled.[11] In mice, extra SIRT1 throughout the body did not lengthen life, while extra SIRT6 lengthened median lifespan by about 27% in males and 15% in females, though both SIRT6 results come from a single laboratory and its earlier study saw the effect in males alone.[12] Lifelong genetic overexpression is not the same thing as taking a pill; the supplements built on this idea are covered under geroprotectors.
Epigenetic clocks are good at comparing groups
An epigenetic clock is an algorithm that reads methylation at a few hundred sites and returns an estimated biological age. The clocks have evolved through generations, each aimed more at health than at calendar age.[13]
- First generation (Horvath, Hannum) was trained to predict age in years, and is only loosely tied to health.
- Second generation (PhenoAge, GrimAge) was trained on clinical markers and death.
- Third generation, DunedinPACE, reports a rate: how fast you are ageing per calendar year. It was built for intervention trials.
- Fourth and fifth generation clocks try to isolate the changes that drive damage rather than merely track age.
The second- and third-generation clocks are the ones that track health. In a large US cohort they were more closely tied to socioeconomic status and health than the first- and fourth-generation versions,[14] and in nearly 19,000 Scottish adults followed for ten years they predicted later disease and death clearly better than the first generation. But adding a clock to a model of standard risk factors improved prediction by more than one percentage point in fewer than one in five of the clock-disease links found.[15]
They are the most developed human aging biomarkers, but not reliably the best. In US adults over 50, a score built from seven inflammation blood measures predicted four-year mortality slightly better than the six clocks it was compared with,[16] while in about 1,100 Berliners aged 60 to 80 followed for about seven years, DunedinPACE was the strongest predictor of death among 14 proposed aging markers.[17]
The clocks have real biological grip. Higher body weight and metabolic dysfunction show up as faster clocks, and an accelerated clock can appear in the blood of women years before a breast-cancer diagnosis.[18] In a large German aging cohort, the pace-of-aging and organ-system clocks tracked cognitive decline most consistently, a result so far reported only in a preprint that has not been peer-reviewed.[19]
Your own clock reading is not worth acting on
The leap from research tool to personal test is where the field gets oversold, for the same reasons as consumer telomere testing.
The clocks do not agree with each other. Estimated side by side in one cohort, nine widely used clocks read different sets of methylation sites and did not correlate strongly among themselves.[20] There is no single "epigenetic age" they are all approximating.
The readings are noisy in two ways. When the same blood sample was measured twice, the older clocks (Horvath, Hannum, PhenoAge) gave ages a median of about one to two and a half years apart, and in the worst case nearly nine, against a real between-person spread of only three to five years; GrimAge and re-engineered versions were far steadier.[21] That lab noise comes from the individual methylation probes the clocks read,[22] and newer clocks have largely fixed it. The second layer has not been fixed: when the same person gives blood again within hours or days, before and after a meal or a stress test, most clocks show only low-to-moderate stability, DunedinPACE included, large enough to make a change in one person's result hard to interpret.[23]
Saliva is not blood. Many consumer kits use saliva or cheek swabs, which contain cheek-lining cells with entirely different methylation. In 83 people aged 9 to 70, mouth samples gave ages that differed from the same person's blood by close to 30 years on average on some clocks, and still matched poorly after allowing for cell mix.[24] Results can also shift with the lab platform, and providers' numbers are not directly comparable.
No regulator has validated any of this. No epigenetic clock is accepted as a clinical endpoint, and regulators such as the US Food and Drug Administration (FDA) and the European Medicines Agency have issued no guidelines on how biomarkers of aging should be validated.[25] Experts in the field list proving that these markers are reliable within a single person as a core unmet need.[26] Companies meanwhile often pair a proprietary, unvalidated algorithm with generic lifestyle advice, and sell products on top. If you test anyway, the DunedinPACE page covers what to ask a provider.
What has actually moved a clock
A handful of large randomised trials have moved a clock, all with small effects found in clock analyses added after the fact or run as side studies; the only trial designed around a clock was a pilot in 43 men. A slower clock is a surrogate marker; none of these trials showed fewer deaths.
Calorie restriction has the best evidence. The CALERIE trial randomised 220 healthy adults without obesity, aged 21 to 50, to a 25% calorie cut or their usual diet for two years. People achieved only about 12% on average, and the restricted group's pace of aging on DunedinPACE slowed by about 2–3%, while PhenoAge and GrimAge showed no significant change. The methylation analysis was not what the trial was designed to test. The authors project that the slowing could mean up to 10–15% lower risk of death, a projection from observational studies rather than something the trial measured, and two of them are named inventors on the clock that moved, which is licensed to a company.[27]
Two supplements gave small signals in older adults. In a three-year trial of Swiss adults aged 70 and over, a daily 1 g omega-3 supplement slowed three of four clocks, by about 1% on the pace-of-aging clock and roughly three to four months on two others; vitamin D alone changed none of them, and this too was an after-the-fact analysis.[28] In a planned side study of 958 older Americans, a daily multivitamin slowed two clocks by roughly a tenth to a fifth of a year per year over two years, and a cocoa-flavanol extract moved none. The authors call the effects small and say more studies are needed to know whether they matter.[29] A weight-loss drug has also slowed several clocks, in a small after-the-fact analysis of a randomised trial in adults with HIV-associated fat gain; see semaglutide and the aging clock.
"Three years younger in eight weeks" is not what it sounds like. The methyl tags are built from nutrients such as folate, vitamin B12, choline and methionine, which is the rationale for diets aimed at the epigenome. A small pilot trial randomised 43 healthy men aged 50 to 72 (38 analysed) to such a diet plus sleep, exercise and relaxation guidance and probiotic and plant-compound supplements. On an older clock measured in saliva, the men on the programme ended about two years younger than they started, while the untreated group drifted about a year older; that drift was not statistically significant but accounts for roughly a third of the headline three-year gap. The study was funded by a supplement company, and two authors use the programme in their clinical practice, earn money from related educational products and are named on a related patent application. It needs replication before it means much.[30]
Exercise, sleep and stress: good for you, unproven for the clock
Exercise is the lever most often said to slow the clocks, and the randomised evidence for that is thin and conflicting. In the same Swiss trial of generally healthy, active over-70s, a home strength programme three times a week against a stretching programme did not change any of the four clocks on its own; it showed up only as a small add-on to omega-3 and vitamin D on one clock.[31] A smaller trial in 124 sedentary breast-cancer survivors found a year of exercise slowed a mortality-linked clock and a fitness-based clock, but measured the clocks in only part of the trial and its summary does not say how large the effect was.[32] A programme of supervised exercise plus nutritional support in frail older adults improved function and one of five epigenetic clocks, but in 47 people randomised, with methylation measured in only 24 of them, and it cannot say which part did the work.[33] Exercise earns its place through muscle, heart and survival, not through the clocks.
For sleep there are associations, not trials. In a Finnish cohort, the robust finding was that symptoms of obstructive sleep apnoea tracked faster epigenetic ageing independently of other health factors (see sleep-disordered breathing); shift work showed no clean dose-response, and among people with little shift-work history, insomnia and sleep deprivation went with more acceleration than in long-term shift workers.[34] Acute sleep loss does shift methylation on the body's clock genes.[35]
Chronic stress is widely held to speed the clocks, but the mechanism is not established. The meditation evidence is narrower than usually reported: long-term meditators showed no overall difference from controls, only a difference in those over about 52 and a small gradient of roughly a quarter of a year less acceleration per extra year of practice, and people who meditate for decades may differ in other ways.[36]
Reprogramming: a frontier in mice, with a cancer problem
The most radical idea is partial reprogramming: briefly switching on the "Yamanaka factors", genes that can turn an adult cell back into a stem cell, so that aged marks are wiped while the cell keeps its identity. In mice it has reversed age-related vision loss, rejuvenated skin and kidney, and, in one company-run study in male mice, about doubled the short remaining lifespan of very old animals, in a study that needs repeating.[37][38][39]
The catch is severe: switched on too long or too strongly, the same factors cause tumours. In mice they produced teratomas in several organs,[40] even a short burst left cancer-like growths behind,[41] and keeping them on continuously killed the animals within days.[42] Making the reset brief and tightly controlled is the central safety challenge. Attempts to do the same with drug-like chemical cocktails have so far worked only in cells in a dish, and their authors say they must be safety-tested in animals before any human use.[43] The first human trial, a small safety study in glaucoma and a type of optic-nerve stroke, began in 2026.[44] None of this is near ready for healthy people.
What to actually do
- Skip the consumer clock test. If you take one anyway, use blood, keep the provider and sample type the same every time, and treat a single change as noise.
- Ignore products sold to lower your epigenetic age. No supplement reliably reverses it; the best supplement results are small slowings in older adults.
- Don't pay for a branded "epigenetic" diet. Folate and vitamin B12 matter for methylation, but the main trial behind such protocols is the small, supplement-company-funded pilot above.
- Get loud snoring or daytime sleepiness checked. Sleep apnoea symptoms are the clearest sleep signal here, and treating apnoea is worth doing for its own sake.
Further reading
- Dhar P, et al. Epigenetic alterations-The silent indicator for early aging and age-associated health-risks. Aging Med (Milton) 2022.[45]
- Shenhar B, et al. Heritability of intrinsic human life span is about 50% when confounding factors are addressed. Science 2026.[46]
- Crimmins EM, et al. Generations of epigenetic clocks and their links to socioeconomic status in the Health and Retirement Study. Epigenomics 2024.[47]
- Mavrommatis C, et al. An unbiased comparison of 14 epigenetic clocks in relation to 174 incident disease outcomes. Nat Commun 2025.[48]
- Higgins-Chen AT, et al. A computational solution for bolstering reliability of epigenetic clocks: Implications for clinical trials and longitudinal tracking. Nat Aging 2022.[49]
- Sehgal R, et al. Biological Versus Technical Reliability of Epigenetic Clocks and Implications for Disease Prognosis and Intervention Response. Aging Cell 2026.[50]
- Apsley AT, et al. Cross-tissue comparison of epigenetic aging clocks in humans. Aging Cell 2025.[51]
- Moqri M, et al. Validation of biomarkers of aging. Nat Med 2024.[52]
- Waziry R, et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nat Aging 2023 — post hoc analysis of a randomised trial.[53]
- Bischoff-Ferrari HA, et al. Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Nat Aging 2025.[54]
- Li S, et al. Effects of daily multivitamin-multimineral and cocoa extract supplementation on epigenetic aging clocks in the COSMOS randomized clinical trial. Nat Med 2026.[55]
- Fitzgerald KN, et al. Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial. Aging (Albany NY) 2021 — see the 2022 correction.[56]
- Roichman A, et al. Restoration of energy homeostasis by SIRT6 extends healthy lifespan. Nat Commun 2021.[57]